Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

FDA and Manufacturers Seek a More Secure Drug Supply Chain

New identifiers and tracking requirements aim to block illegitimate products.
Apr 2, 2014

New identifiers and tracking requirements aim to block illegitimate products.

Manufacturers Struggle with Breakthrough Drug Development

Accelerated testing and production create challenges in documenting product quality.
Mar 2, 2014

Accelerated testing and production create challenges in documenting product quality.

FDA Focuses on Drug Appearance and Attributes

FDA urges manufacturers to examine how shape, size, and color may affect patient safety and enhance treatment adherence.
Feb 2, 2014

FDA urges manufacturers to examine how shape, size, and color may affect patient safety and enhance treatment adherence.

Metrics Sought to Ensure Drug Quality

Regulators work with manufacturers to improve systems for measuring product performance and manufacturing reliability.
Jan 2, 2014

Regulators work with manufacturers to improve systems for measuring product performance and manufacturing reliability.

Analyzing Nano Drugs

Dec 12, 2013

FDA details efforts to evaluate potential risks from use of nanomaterials in drug products and discuss analytical considerations, impact on stability, safety, and toxicology effects.

Super Oversight for Generics

Dec 12, 2013

OGD is under pressure to improve review operations.

Congress Revises Rules for Drug Compounding and Supply-Chain Security

Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.
Dec 4, 2013

Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.

Opioid Regulation Challenges FDA and Manufacturers

New policies and products seek to maintain access to pain medicines while curbing rampant abuse.
Dec 2, 2013

New policies and products seek to maintain access to pain medicines while curbing rampant abuse.

FDA Seeks Metrics to Define Drug Quality

Manufacturing standards are considered key to preventing drug recalls and shortages.
Nov 13, 2013

Manufacturing standards are considered key to preventing drug recalls and shortages.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here